Deputy Minister of State-Owned Enterprises (BUMN) Kartika Wirjoatmodjo said the settlement of PT Indofarma Tbk's (INAF) obligations to employees would be fulfilled from selling assets.
Based on information collected by the Indofarma Workers Union (SP Indofarma), there are employee rights that are in arrears of Rp95 billion. This figure includes obligations to Indofarma employees amounting to Rp65 billion and Indofarma Global Medika (IGM) worth Rp30 billion.
"Later, our employees will provide asset sales that we will sell in stages to resolve personnel issues in order to get efficient in the future," he said in a Working Meeting with Commission VI of the DPR RI, at the DPR Building, Parliament Complex, Jakarta, Monday, September 2.
The man who is familiarly called Tiko explained that his party had carried out a homologation decision from the Indofarma Debt Payment Obligation Postponement (PKPU) trial.
The results, he said, had prepared a number of portions, both for creditors, vendors, and employees.
Regarding the sale of Indofarma's assets, Tiko said, later the Pharmaceutical BUMN Holding, Bio Farma will help with the process.
SEE ALSO:
Bio Farma will buy assets owned by Indofarma.
"Well, we are currently allocating very adequate assets, so later with the help of the Bio Farma holding, this asset will be completed by Holding, purchased to then use for gradual employee settlement," he said.
When asked about the amount of asset value and obligations to employees, Tiko emphasized that he would maximize the fulfillment of the proceeds from the sale of assets.
"It will depend on the selling price of assets, but we will try to maximize it from the assets that we have now agreed on," he explained.
The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)
